医学
心脏病学
内科学
血运重建
冠状动脉疾病
心肌梗塞
危险系数
比例危险模型
灌注
心肌灌注成像
冲程(发动机)
置信区间
机械工程
工程类
作者
K. Lance Gould,Nils P. Johnson,Amanda E. Roby,Tung Nguyen,Richard L. Kirkeeide,Mary Haynie,Dejian Lai,Hongjian Zhu,Monica Patel,Richard W. Smalling,Sal Arain,Prakash Balan,Tom C. Nguyen,Anthony L. Estrera,Stefano Sdringola,Mohammad Madjid,Angelo Nascimbene,Pranav Loyalka,Biswajit Kar,Igor D. Gregorič,Hazem Safi,David L. McPherson
标识
DOI:10.2967/jnumed.118.211953
摘要
Because randomized coronary revascularization trials in stable coronary artery disease (CAD) have shown no reduced myocardial infarction (MI) or mortality, the threshold of quantitative myocardial perfusion severity was analyzed for association with reduced death, MI, or stroke after revascularization within 90 d after PET. Methods: In a prospective long-term cohort of stable CAD, regional, artery-specific, quantitative myocardial perfusion by PET, coronary revascularization within 90 d after PET, and all-cause death, MI, and stroke (DMS) at 9-y follow-up (mean ± SD, 3.0 ± 2.3 y) were analyzed by multivariate Cox regression models and propensity analysis. Results: For 3,774 sequential rest-stress PET scans, regional, artery-specific, severely reduced coronary flow capacity (CFC) (coronary flow reserve ≤ 1.27 and stress perfusion ≤ 0.83 cc/min/g) associated with 60% increased hazard ratio for major adverse cardiovascular events and 30% increased hazard of DMS that was significantly reduced by 54% associated with revascularization within 90 d after PET (P = 0.0369), compared with moderate or mild CFC, coronary flow reserve, other PET metrics or medical treatment alone. Depending on severity threshold for statistical certainty, up to 19% of this clinical cohort had CFC severity associated with reduced DMS after revascularization. Conclusion: CFC by PET provides objective, regional, artery-specific, size-severity physiologic quantification of CAD severity associated with high risk of DMS that is significantly reduced after revascularization within 90 d after PET, an association not seen for moderate to mild perfusion abnormalities or medical treatment alone.